Page 1 of Clinical Trials for Drug Irinotecan 5 FU folinic acid, 220 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma
Last Updated: February 5, 2012
Condition(s): Colorectal Carcinoma
2
Terminated
A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer
Last Updated: March 13, 2007
Condition(s): Colorectal Neoplasms; Diarrhea
3
Completed
Fluorouracil and Leucovorin Plus Either Irinotecan or Oxaliplatin With or Without Cetuximab in Treating Patients With Previously Untreated Metastatic Adenocarcinoma of the Colon or Rectum
Last Updated: April 12, 2011
Condition(s): Colorectal Cancer
4
Active, not recruiting
Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer
Last Updated: January 3, 2009
Condition(s): Colorectal Cancer
5
Completed
Combination Chemotherapy in Treating Patients With Stage III Colon Cancer
Last Updated: March 24, 2012
Condition(s): Colorectal Cancer
6
Active, not recruiting
Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
Last Updated: February 6, 2009
Condition(s): Colorectal Cancer
7
Active, not recruiting
Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer
Last Updated: August 2, 2011
Condition(s): Anal Cancer; Carcinoma of the Appendix; Colorectal Cancer; Esophageal Cancer; Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Gastric Cancer; Gastrointestinal Carcinoid Tumor; Gastrointestinal Stromal Tumor; Liver Cancer; Pancreatic Cancer; Small Intestine Cancer
8
Completed
Ph II Trial of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Second-line Treatment of Metastatic Colorectal Cancer
Last Updated: January 13, 2012
Condition(s): Colorectal Cancer (CRC)
9
Completed
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
Last Updated: April 13, 2012
Condition(s): Colorectal Cancer
10
Completed
Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
Last Updated: July 23, 2008
Condition(s): Colorectal Cancer
11
Recruiting
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Last Updated: April 7, 2011
Condition(s): Colorectal Cancer
12
Completed
Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin
Last Updated: October 3, 2011
Condition(s): Carcinoma of Unknown Primary; Colorectal Cancer; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
13
Active, not recruiting
Comparison of Adjuvant Chemotherapy Regimens in Treating Patients With Stage II or Stage III Rectal Cancer Who Are Receiving Radiation Therapy and Fluorouracil Before or After Surgery
Last Updated: February 6, 2009
Condition(s): Colorectal Cancer
14
Active, not recruiting
Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer
Last Updated: March 26, 2012
Condition(s): Esophageal Cancer; Gastric Cancer; Liver Cancer
15
Active, not recruiting
Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer
Last Updated: January 3, 2009
Condition(s): Colorectal Cancer
16
Recruiting
A Genotype-guided Study of Irinotecan Administered in Combination With 5-fluorouracil/Leucovorin (FOLFIRI) and Bevacizumab in Advanced Colorectal Cancer Patients
Last Updated: June 14, 2011
Condition(s): Metastatic Colorectal Cancer
17
Active, not recruiting
Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer
Last Updated: February 22, 2012
Condition(s): Esophageal Cancer; Gastric Cancer
18
Completed
Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal Cancer
Last Updated: June 22, 2010
Condition(s): Colorectal Cancer
19
Active, not recruiting
Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancer
Last Updated: July 23, 2008
Condition(s): Esophageal Cancer
20
Completed
Cetuximab Combined With Irinotecan in First-line Therapy for Metastatic Colorectal Cancer (CRYSTAL)
Last Updated: May 27, 2011
Condition(s): Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Irinotecan+5+FU+folinic+acid

Page 1 of Clinical Trials for Drug Irinotecan 5 FU folinic acid, 220 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About